| Old Articles: <Older 8631-8640 Newer> |
|---|
 |
Pharmaceutical Executive
July 1, 2013
Richie Etwaru |
Innovation Calls Across the C-suite: Lessons From Wall Street The lifeblood of the life sciences industry is continuous innovation; it is not a business that can survive by standing still.   |
Pharmaceutical Executive
July 1, 2013
Jill Wechsler |
Seeking Supply Chain Security FDA wants pharma leaders to do more to ensure drug quality at home and abroad. |
Pharmaceutical Executive
July 1, 2013
William Looney |
Talent, Terror, and the Turnaround We offer news on 15 new Emerging Pharma Leaders, business innovation, and terrorism threats to the pharmaceutical industry. |
Chemistry World
July 24, 2013
Andy Extance |
Lilly freezes pay as patent cliff looms The company is looking to save money ahead of the imminent expiration of two key patents, from which it faces a 20% fall in revenue. |
Chemistry World
July 12, 2013
Phillip Broadwith |
GSK under investigation over corruption in China Chinese police are investigating GlaxoSmithKline over claims of bribery and tax-related crimes. |
Chemistry World
July 9, 2013
Daniel Johnson |
Evotec moves business back to UK German drug discovery company Evotec will close its operations in Thane, India, and move them back to its Abingdon, UK, facility. |
Chemistry World
July 2, 2013
Phillip Broadwith |
Biosimilar drugs step up complexity The first ever generic monoclonal antibody therapies have been recommended for approval in Europe. |
Chemistry World
July 2, 2013
Sonja Hampel |
Thalidomide teams-up with turmeric to kill myeloma cells Cancer researchers in the US and China have combined the turmeric spice pigment curcumin and the drug thalidomide to create hybrid compounds that can kill multiple myeloma cells. |
Chemistry World
July 2, 2013
Derek Lowe |
Target acquired Phenotypic screening has recently seen a revival in popularity. This technique assesses drug candidates first by their effects in some organism, then works back to their causes. It can be an effective strategy, but when you find some interesting results, the need to explain them can become acute. |
Information Today
July 2, 2013 |
Thomson Reuters Offers Clinical Trial Intelligence Solutions These solutions improve clinical trials, speed up product development and release, and help professionals strengthen portfolios and R&D strategy. |
| <Older 8631-8640 Newer> Return to current articles. |
